10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status.

Saved in:
Bibliographic Details
Title: 10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status.
Authors: Cortellini, A.1 (AUTHOR), Filetti, M.2 (AUTHOR), Citarella, F.3 (AUTHOR), Giusti, R.4 (AUTHOR), Russano, M.5 (AUTHOR), Grossi, F.6 (AUTHOR), Gelibter, A.J.7 (AUTHOR), Pecci, F.8 (AUTHOR), De Tursi, M.9 (AUTHOR), Macerelli, M.10 (AUTHOR), Nigro, O.11 (AUTHOR), Ferrara, M.G.12 (AUTHOR), Buti, S.13 (AUTHOR), Mazzoni, F.14 (AUTHOR), Cantini, L.15 (AUTHOR), Migliorino, M.R.16 (AUTHOR), Addeo, A.17 (AUTHOR), Adamo, V.18 (AUTHOR), Russo, A.19 (AUTHOR), Pinato, D.J.20 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1378-S1378. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2021.10.026